Return On Assets of Calidi Biotherapeutics, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Calidi Biotherapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Calidi Biotherapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -152%, a 56% increase year-over-year.
  • Calidi Biotherapeutics, Inc. annual Return On Assets for 2024 was -255%, a 153% decline from 2023.
  • Calidi Biotherapeutics, Inc. annual Return On Assets for 2023 was -101%, a 403% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Calidi Biotherapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -152% +192% +56% 01 Jul 2025 30 Sep 2025
Q2 2025 -176% +43% +20% 01 Apr 2025 30 Jun 2025
Q1 2025 -189% -39% -26% 01 Jan 2025 31 Mar 2025
Q4 2024 -255% -155% -153% 01 Oct 2024 31 Dec 2024
Q3 2024 -344% -238% -225% 01 Jul 2024 30 Sep 2024
Q2 2024 -219% -122% -125% 01 Apr 2024 30 Jun 2024
Q1 2024 -150% -120% -395% 01 Jan 2024 31 Mar 2024
Q4 2023 -101% -81% -403% 01 Oct 2023 31 Dec 2023
Q3 2023 -106% 01 Jul 2023 30 Sep 2023
Q2 2023 -97% 01 Apr 2023 30 Jun 2023
Q1 2023 -30% 01 Jan 2023 31 Mar 2023
Q4 2022 -20% 01 Oct 2022 31 Dec 2022

Calidi Biotherapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -255% -155% -153% 01 Jan 2024 31 Dec 2024
2023 -101% -81% -403% 01 Jan 2023 31 Dec 2023
2022 -20% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.